£0.03
£0.00 (0.00%)
End-of-day quote: 05/20/2024
AIM:AGY
Allergy Therapeutics Annual Report
| Year | Year | 2023 | ||
|---|---|---|---|---|
| Rev. | Revenue |
|
£59.59M | |
| GM % | Gross Margin % |
|
55.79% | |
| OM | Operating Margin |
|
-59.05% | |
| EPS | Earnings Per Share |
|
£0.00 | £-0.08 |
| Div. | Dividends |
|
£0.00 | |
| PR % | Payout Ratio % |
|
0 | |
| Sha. | Shares |
|
679.1m | |
| OCF | Operating Cash Flow |
|
£-28.88M | |
| FCF | Free Cash Flow |
|
£-34.46M | |
| FCFS | Free Cash Flow Per Share |
|
£-0.05 |
